WHO Guideline on the Use of Safety-engineered Syringes for Intramuscular, Intradermal and Subcutaneous Injections in Health Care Settings

April 2017
More details
  • Publisher
    World Health Organization
  • Published
    20th April 2017
  • ISBN 9789241549820
  • Language English
  • Pages 46 pp.
  • Size 8.25" x 11.75"

This guideline provides global, evidence-based recommendations on the use of safety-engineered injection devices to prevent the re-use of syringes and/or prevent needle-stick injuries in health care workers. The ultimate aim is to make injection practices safer for patients and health workers and to prevent the injection-related transmission of deadly viruses, particularly HIV, hepatitis C, and hepatitis B.

The policy recommendation aims to support Member States and development partners in making informed decisions on the appropriateness of introducing safety-engineered syringes for all injections in health care settings.

The target audience for this guideline includes the staff from ministries, agencies, and other entities that have a critical role to play in the adoption and implementation of the policy, namely in endorsing the policy, manufacturing the devices, ensuring their procurement and distribution at country level, and promoting their correct use by health care providers and their evaluation in terms of safety and effectiveness.

World Health Organization

World Health Organization is a Specialized Agency of the United Nations, charged to act as the world's directing and coordinating authority on questions of human health. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends.